Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 06:11 am Purchase | 13G | ENLIVEX THERAPEUTICS LTD COM O ENLV | Nussbaum Ran | 68,580 0.7% | 68,580 (New Position) | View |
| 2019-09-09 4:08 pm Sale | 13G | ENLIVEX THERAPEUTICS LTD COM O ENLV | Hobi Michael | 498,432 4.93% | -192,878 (-27.90%) | View |
| 2019-06-27 3:10 pm Purchase | 13G | ENLIVEX THERAPEUTICS LTD COM O ENLV | HBL- HADASIT BIO-HOLDINGS LTD. | 1,798,727 17.79% | 1,798,727 (New Position) | View |
| 2019-06-26 12:16 pm Purchase | 13G | ENLIVEX THERAPEUTICS LTD COM O ENLV | Kretzmer & Associates PLLC | 830,973 8.22% | 830,973 (New Position) | View |
| 2019-06-26 10:52 am Purchase | 13G | ENLIVEX THERAPEUTICS LTD COM O ENLV | KIP Global Pharma-Ecosystem Private Equity Fund | 1,417,950 14.02% | 1,417,950 (New Position) | View |
| 2019-06-19 3:07 pm Purchase | 13G | ENLIVEX THERAPEUTICS LTD COM O ENLV | Hobi Michael | 691,310 6.84% | 691,310 (New Position) | View |
| 2019-05-31 12:17 pm Purchase | 13D | ENLIVEX THERAPEUTICS LTD COM O ENLV | NOVIK SHAI A | 882,515 8.6% | 882,515 (New Position) | View |